欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/0344/004
药品名称
Cirantan 5 mg
活性成分
rosuvastatin 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Astra Zeneca Louis Pasteurlaan 5 2719 EE Zoetermeer
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
许可日期
2004/11/02
最近更新日期
2014/12/22
药物ATC编码
C10AA07 rosuvastatin
申请类型
TypeLevel1:
Line Extension
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
nlh-343-6 common-combined-crestor-proposedday59annotated_RMS assessment
Date of last change:2014/06/20
Final SPC
|
Cirantan common-combined-proposed-clean
Date of last change:2012/12/14
Final PL
|
common-pl-cirantantabletnonannotatedpending 02 July 2012
Date of last change:2012/07/10
Final Labelling
|
Annex 1Label QRD (Crestor 10 mg)
Date of last change:2010/03/24
市场状态
Withdrawn(注:已撤市)
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase